Takeda’s savings programme is no longer an abstract investor slide. It has moved from corporate language […]
The JPY 200 billion savings target currently dominating Takeda’s internal dialogue isn’t just a number on […]
Just now, AstraZeneca is making headlines with a $5.3 billion AI research partnership with China’s […]
Embracing Opportunities in Japan With great excitement and a sense of humble pride, I share our […]